We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

R&D Systems to Develop Cytokine Assays for Beckman

By HospiMedica staff writers
Posted on 22 Oct 2003
A nonexclusive, multi-year agreement has been announced by Beckman Coulter (Fullerton, CA, USA) and R&D Systems (Minneapolis, MN, USA) under which R&D Systems will develop automated cytokine assays and manufacture assay components designed for Beckman's Access family of immunoassay systems.

R&D Systems will develop and manufacture immunoassays based on Beckman Coulter's magnetic particle, chemiluminescent immunoassay technology. More...
The initial focus of the agreement will serve to expand Beckman's leadership position in anemia testing to include erythropoietin, a principal cytokine factor regulating red blood cell production, and soluble transferring receptor (STFR), considered the best indicator of iron deficiency.

Beckman Coulter currently offers a wide array of tests for the diagnosis and monitoring of anemia that are run on its hematology analyzers. The addition of new assays for biologics and cytokines will enhance the company's portfolio of products.

"Because we maintain a best-of-breed philosophy around our assay design, development, and manufacture, R&D Systems was clearly an excellent partner,” said Michael Whelan, vice president, immunoassay and nucleic acid testing, for Beckman Coulter. "Their expertise will be instrumental in our efforts to strengthen our position in the automated immunoassay market.”





Related Links:
Beckman Coulter
R&D Systems

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Rapid Sepsis Test
SeptiCyte RAPID
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.